{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2, including R1441G, are linked to Parkinsonâ€™s disease through impairment of phosphorylation-dependent 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of LRRK2 mutations in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Affinity purification and mass spectrometry were used to assess phosphorylation sites and protein interactions.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease mechanism by studying kinase activity and protein binding."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Experiments were performed with wild-type and mutant controls, including multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants (R1441G, Y1699C, G2019S) were used as positive controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls of known pathogenic status were included."
        }
      ],
      "evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Y1699C mutation impairs phosphorylation-dependent binding of 14-3-3, contributing to PD.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Standard assays for kinase activity and protein interaction were used.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Multiple replicates and wild-type controls were employed.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Pathogenic variants, including Y1699C, were tested as positive controls.",
          "judgment": "Yes"
        }
      ],
      "evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "G2019S mutation disrupts phosphorylation and 14-3-3 binding, causing PD.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Affinity purification and mass spectrometry were used appropriately.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Experiments included wild-type controls and multiple replicates.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Pathogenic variants, including G2019S, were tested as positive controls.",
          "judgment": "Yes"
        }
      ],
      "evidence_strength": "PS3_moderate"
    }
  ]
}